Appearance | White Powder |
Purity / Analysis Method | 99.9% (HPLC) |
Melting Point | 254 °C |
Loss On Drying | NMT 0.2% |
Specific Rotation | -1° to +1 |
Arsenic | NMT 1 µg/g |
Residue On Ignition | NMT 0.1% |
Solubility | Soluble in Chloroform and DMSO |
9-Fluoro-3,7-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic Acid
Purity / Analysis Method | 98 % – 101.5% (HPLC) |
Molecular Formula / Molecular Weight | C18H20FN3O4 = 361.37 |
Physical State (20 deg.C) | Solid |
CAS RN | 82419-36-1 |
Unit | Price |
10 g | 2000 |
25 g | 2950 |
100 g | 7500 |
Appearance | White Powder |
Purity / Analysis Method | 99.9% (HPLC) |
Melting Point | 254 °C |
Loss On Drying | NMT 0.2% |
Specific Rotation | -1° to +1 |
Arsenic | NMT 1 µg/g |
Residue On Ignition | NMT 0.1% |
Solubility | Soluble in Chloroform and DMSO |
Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
---|